Journal of Pharmacovigilance and Quality Assurance ISSN: 3108-2343 (Online)

Authors: Siddharth Joshi, Dr. Smita Agarwal

Abstract: This paper explores the importance of quality assurance (QA) in clinical trials, focusing on the best practices that can be adopted to minimize risks and enhance drug safety. It covers strategies for maintaining high-quality standards in clinical trials, with an emphasis on safety monitoring, data integrity, and risk minimization techniques. The goal is to provide a comprehensive overview of the methods used by clinical researchers and organizations to ensure that clinical trials are conducted ethically, effectively, and with a high level of reliability.

Keywords: Clinical Trials, Quality Assurance, Drug Safety, Risk Minimization, Safety Monitoring, Data Integrity

Author: Rekha Joshi

Abstract: Pharmacovigilance is an essential aspect of drug safety evaluation, traditionally relying on data from clinical trials and spontaneous reporting systems. However, with the increasing complexity of medical treatments and the diversity of patient populations, there is a growing need to integrate realworld data, particularly from patients themselves, to enhance pharmacovigilance practices. Patient-Reported Outcomes (PROs), which include data collected directly from patients regarding their health status and the effects of treatments, offer a novel approach to improving the safety evaluation of drugs. This paper explores the significance of integrating PROs in pharmacovigilance, examining how patient feedback can supplement traditional safety monitoring systems, identify adverse drug reactions (ADRs) more effectively, and ultimately improve patient safety. Furthermore, the paper highlights the challenges and opportunities associated with the implementation of PROs in pharmacovigilance, proposing strategies for better utilization of patient-centered data in assessing drug safety.

Keywords: Pharmacovigilance, Patient-Reported Outcomes, Drug Safety, Adverse Drug Reactions, Real-World Data, Patient-Centric, Safety Evaluation

Authors: Rohan Kumar, Sarita Gupta

Abstract: This paper explores the effectiveness of regulatory frameworks and pharmacovigilance practices across various countries in ensuring drug safety. By analyzing case studies from key regions, this study assesses how regulatory policies contribute to monitoring and improving the safety of drugs post-market. The research aims to identify the strengths and weaknesses of these frameworks and recommend potential improvements. Through comparative analysis, the paper investigates the role of both governmental and non-governmental agencies in managing pharmacovigilance and ensuring patient safety.

Keywords: Regulatory Policies, Drug Safety, Pharmacovigilance, Global Frameworks, Drug Regulation, Post-Market Surveillance, Case Studies

Author: Neelam Rani

Abstract: Pharmacovigilance plays a critical role in ensuring the safety of pharmaceutical products by identifying, evaluating, and preventing adverse drug reactions (ADRs). Traditional pharmacovigilance methods, while effective, often face challenges in processing vast amounts of data from diverse sources, which limits the ability to detect potential risks early. The rise of Artificial Intelligence (AI) and Machine Learning (ML) offers transformative opportunities to enhance drug safety monitoring. This paper explores how AI and ML techniques, such as predictive analytics, natural language processing, and deep learning, can be leveraged to improve pharmacovigilance by enabling faster detection of ADRs, predicting safety signals, and improving decision-making processes in drug safety. We also discuss the integration of AI and ML in real-world data and pharmacovigilance systems, highlighting challenges, regulatory considerations, and future prospects for these technologies in drug safety surveillance.

Keywords: Pharmacovigilance, Artificial Intelligence, Machine Learning, Drug Safety, Adverse Drug Reactions, Predictive Analysis, Early Detection, Surveillance, Signal Detection, Natural Language Processing, Real-World Data, Drug Safety Monitoring

Author: Sandeep Yadav

Abstract: Pharmacovigilance plays a crucial role in ensuring patient safety by identifying, assessing, and mitigating drug-related risks. With the increasing complexity of pharmaceutical products and their global usage, managing adverse drug reactions (ADRs) has become a priority for health authorities and pharmaceutical companies. This paper explores proactive approaches to pharmacovigilance, focusing on the strategies employed for early detection, comprehensive assessment, and effective management of ADRs. A detailed analysis of current methodologies in risk management, including signal detection, risk assessment tools, regulatory frameworks, and post-market surveillance systems, will be presented. Emphasis will also be placed on the importance of a risk-based approach to drug safety monitoring. The paper concludes with recommendations for improving pharmacovigilance practices and ensuring a proactive stance on drug safety.

Keywords: Pharmacovigilance, risk management, adverse drug reactions, drug safety, signal detection, regulatory frameworks, safety monitoring, risk mitigation.

Authors: Kalpana Zore, Sandhya Kadam, Dr. Vivekkumar Redasani 

Abstract: The goal of this review is to establish the significance of cleaning validation in the pharmaceutical industry. Pharmaceutical product and active pharmaceutical ingredients (APIs) can be contaminated by other pharmaceutical products or APIs, by cleaning agents, by microorganisms or by other materials e.g. air borne particles, dust, lubricants, raw materials, intermediates, etc. Cleaning procedure is the process of assuring that cleaning procedures effectively remove the potentially dangerous substances from equipments. This can be minimized by proper cleaning of equipment, apparatus as well as the processing area. So it is necessary to validate the cleaning procedures to ensure safety, efficacy, quality of the subsequent batches of drug product and regulatory requirements in Pharmaceutical product manufacture. It briefly provides an overview on mechanism of contamination, cleaning mechanisms, cleaning agents, procedure of cleaning, and sampling techniques.

Keywords: Cleaning validation, Objective of cleaning validation, cleaning mechanism, cleaning agent, cleaning validation program, cleaning methods, sampling technique. Revalidation

Authors: Aishwarya Nale, Aishwarya Mali, Sandhya Kadam, Vivekkumar Redasani

Abstract: The purpose of documents as a data source in qualitative research is examined in this article, which also explores document analysis procedures in the context of real-life research experiences. The paper, which is aimed at research beginners, presents a step-by-step method for document analysis. It discusses the nature and types of documents, as well as the Advantages and method of document analysis, and provides concrete instances of how documents might be used in the research process. A grounded theory study is used to demonstrate the use of document analysis. We may notice major trends in information systems that have an impact on their evolution, including documentation. As a result, the approaches to systems from the perspectives of IT project management, roles, and resource allocation, as well as the relevance of documentation for the success of a development project, have changed.

Keywords: Documentation, Batch manufacturing record (BMR), Manufacturing formula record (MFR), Standard operating procedure (SOP), Good documentation practices (GDP), and Quality audit.

Authors: Sayali Chavan, Saurabh Bhilare, Aishwarya Mali, Pooja Kadam, Vivekkumar Redasani 

Abstract: Asthma is a common seditious complaint that has wide clinical characteristics of the airway of the lungs. Asthma symptoms can be averted by avoiding triggers like allergens and by effective gobbled treatment almost cases with asthma can be duly managed with current drugs. Asthma-related deaths are seen especially in the severe asthma group. Asthma is a miscellaneous complaint, conforming to different phenotypes. It requires a multidisciplinary approach to treatment operation. Severe asthma may suddenly develop in early time in complaint or overtime. There has been substantiation linking age, inflammation, genetics, terrain, and length of illness to severe asthma. The remedy of severe asthma may be told by both environmental and heritable variables.Some traditional shops with Antiasthamatic exertion are Aerva lanta Linn (Amaranthaceae), Ageratum conyzoides, Asystasia gangetica (Acanthaceae), Ficus bengalensis Linn(Moraceae), Piper betel Linn, Argemone Mexicana Linn (Papaveraceous), Datura stramonium Linn(Solanaceae).

Keywords: Asthma, Epidemiology, Pathophysiology, Risk factors, Antiasthamatic drugs.

Authors: Sakshi S. Phadtare, Sandhya R. Shinde (Kadam), Dr. Vivekkumar K. Redasani

Abstract: The primary goal of any industry and products it produces is quality. The pharmaceutical industry is currently interested in a variety of perspectives on achieving such quality, which is maintained by validation. Validation is documented proof that offers a high degree of assurance. One of subjects that the pharmaceutical industry is most familiar with these days is validation. This paper goes into great detail regarding the significance of pharmaceutical validation. Prioritizing quality is always essential while analyzing the products. The types of validation, equipment validation, process validation, cleaning, and analytical method validation are all covered in this article. The process of ensuring that the analytical technique used for a particular test is appropriate for its intended use is known as validation.

Keywords: Validation, Process Validation, Prospective Validation, Retrospective Validation, Concurrent & Revalidation.

Author:  Shubhan Patel, Shyam Bhutwala, Dr. Jitendra Patel, Dr. Umesh Upadhyay

Abstract: The pharmaceutical packaging landscape has witnessed significant innovation and transformation, driven by evolving regulatory standards, patient expectations, and industry demands. This comprehensive review explores the latest advancements, addressing the multifaceted role of pharmaceutical packaging in safeguarding product integrity and patient safety. Beyond containment, packaging shields medications from external factors and helps extend shelf life, reduce errors, and ensure compliance. Key trends in pharmaceutical packaging include sustainable materials, anti-counterfeiting technologies, child-resistant designs, patient-centric solutions, and automation in alignment with Industry 4.0 principles. Sterile packaging is paramount in healthcare, and the sustainability imperative is reshaping packaging materials and processes. Smart packaging, including NFC tags and serialization, offers enhanced patient adherence and anti-counterfeiting measures. With a focus on improving patient outcomes, pharmaceutical packaging is undergoing an era of remarkable change, balancing functionality, safety, and sustainability.

Keywords: Pharmaceutical Packaging, Sustainability, Sterile Packaging, Smart Packaging, Serialization, Challenges, Trends, Eco-friendly Materials.

Authors: Ugrapal Singh, Prof. Bindeshwari Prasad Gupta

Abstract: Pharmacovigilance plays a crucial role in ensuring the safety of pharmaceutical products by monitoring and assessing adverse drug reactions (ADRs) throughout their lifecycle. Traditional pharmacovigilance methods heavily rely on spontaneous reporting systems and clinical trials data. However, the advent of electronic health records (EHRs) and big data analytics has provided an opportunity to enhance pharmacovigilance through the incorporation of real-world evidence (RWE). This paper explores the evolving role of RWE in pharmacovigilance, emphasizing the utilization of EHRs and big data analytics for improved safety monitoring and regulatory decision-making.

Keywords: Pharmacovigilance, Real-World Evidence, Electronic Health Records (EHRs), Big Data Analytics, Drug Safety, Regulatory Decision Making, Patient-Centric Pharmacovigilance, Signal Detection, Predictive Analytics.

Author: Ramesh Chandra Chaurasia

Abstract: Precision medicine, characterized by the customization of medical treatment to the individual characteristics of each patient, has revolutionized healthcare. In this context, pharmacovigilance plays a pivotal role in ensuring the safety of pharmaceutical interventions. This paper explores the evolving landscape of pharmacovigilance in the era of precision medicine, emphasizing the need for tailored drug safety monitoring based on individual patient profiles. The integration of advanced technologies, big data analytics, and personalized medicine approaches is discussed, with a focus on optimizing adverse event detection and management.

Keywords: Precision Medicine, Pharmacovigilance, Drug Safety Monitoring, Personalized Medicine, Big Data Analytics, Electronic Health Records (EHRs), Genomic Data, Wearable Devices, Social Media, Pharmacogenomics, Biomarkers.

Authors: Sushil Kumar Bajpai, Brijendra Pandey

Abstract: Pharmacovigilance, as a critical component of drug safety monitoring, has traditionally relied on healthcare professional reports and regulatory databases. However, there is a growing recognition of the importance of incorporating patient perspectives into the pharmacovigilance process. This paper explores patient-centric approaches to pharmacovigilance, specifically focusing on the integration of patient-reported outcomes (PROs) and social media data. The aim is to enhance the early detection and evaluation of adverse drug reactions, providing a more comprehensive understanding of drug safety from the patient's viewpoint.

Keywords: Pharmacovigilance, Patient-reported outcomes (PROs), Social media data, Drug safety, Adverse drug reactions, Patient-centered care, Real world evidence, Artificial intelligence, Data harmonization, Healthcare analytics.

Authors: Dr. Satish Chandra Tiwari, Dinesh Kumar2

Abstract: Pharmacovigilance, the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems, is crucial for ensuring the safety of pharmaceutical products. As the volume of health-related data continues to grow, the integration of artificial intelligence (AI) and machine learning (ML) technologies has become instrumental in revolutionizing pharmacovigilance surveillance. This paper provides a comprehensive review of the impact of AI and ML in enhancing pharmacovigilance, emphasizing their applications, challenges, and future prospects.

Keywords: Pharmacovigilance, Artificial Intelligence (AI), Machine Learning (ML), Drug Safety, Signal Detection, Predictive Analytics, Natural Language Processing (NLP), Data Mining, Real-World Evidence (RWE), Personalized Medicine.

Authors: Pakanikar Satish Limbaji, Vinod Shirke

Abstract: Pharmacovigilance, the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems, plays a crucial role in ensuring the safety of pharmaceutical products worldwide. In recent years, there has been a growing recognition of the need for global harmonization of pharmacovigilance regulations to enhance efficiency, consistency, and patient safety. This paper explores the challenges and opportunities associated with achieving global harmonization in pharmacovigilance, with a focus on regulatory frameworks and the potential benefits for public health.

Keywords: Pharmacovigilance, Global harmonization, Regulatory frameworks, Adverse drug reactions. Patient safety, Drug safety, International collaboration, Regulatory convergence, Risk communication, Capacity building.

Authors:  Kajol Singh, Ruchika Pandit, Dr. K. R Nandan

Abstract: Pharmacovigilance is a critical component of drug safety surveillance, aiming to detect, assess, understand, and prevent adverse drug reactions (ADRs). With the advent of digital technologies and the exponential growth of data, there is an opportunity to leverage big data to enhance pharmacovigilance practices. This paper explores the potential of digital technologies, such as electronic health records (EHRs), social media mining, wearable devices, and machine learning algorithms, to improve drug safety surveillance and pharmacovigilance. It discusses the benefits, challenges, and ethical considerations associated with leveraging big data for enhanced drug safety surveillance, emphasizing the need for robust methodologies and data privacy protection. The paper concludes by highlighting the future prospects of digital technologies in pharmacovigilance and their potential to revolutionize drug safety surveillance.

Keywords: Pharmacovigilance, Drug safety surveillance, Digital technologies Big data analytics, Electronic health records, Social media mining, Wearable devices, Machine learning, Adverse drug reactions, Signal detection, Causality assessment, Personalized medicine, Data quality, Data privacy, Ethical considerations, Regulatory frameworks, Collaboration, Real-time monitoring, Patient outcomes, Drug regulation

Authors:  Shafiqul Islam, Tasbirul Islam

Abstract: Quality assurance systems play a vital role in ensuring the safety, efficacy, and quality of pharmaceutical products and services provided in pharmacy practice. This paper examines the implementation and impact of quality assurance systems in pharmacy practice, highlighting their significance in promoting patient safety, optimizing medication management, and enhancing overall healthcare outcomes. It explores the various components of quality assurance systems, including standard operating procedures, documentation, staff training, and regulatory compliance. Furthermore, the paper discusses the benefits and challenges associated with implementing quality assurance systems and provide insights into emerging trends and technologies that can further enhance their effectiveness.

Keywords: Quality assurance systems, pharmacy practice, patient safety, medication management, regulatory compliance, standard operating procedures, documentation, staff training, auditing, continuous quality improvement, automation, robotics, electronic health records, data analytics, blockchain technology, telepharmacy.

Authors: Anuja Narayanan, Akansha Bhardwaj

Abstract: Pharmacies play a critical role in the healthcare system by providing safe and effective medications to patients. Ensuring medication quality and safety is of paramount importance to protect patient health and prevent adverse drug events. Quality control measures implemented in pharmacies are crucial in maintaining the integrity, potency, and safety of medications. This paper explores the significance of quality control measures in pharmacies and their role in upholding medication quality and safety. It highlights various aspects of quality control, including procurement, storage, dispensing, and patient education. By understanding and implementing robust quality control measures, pharmacies can contribute to improved patient outcomes and a safer healthcare environment.

Keywords: Medication quality, Medication safety, Quality control measures, Pharmacies, Procurement, Storage, Dispensing, Patient education, Patient safety, Medication errors.

Authors: Dr. Narasinga Psathak, Vidhyut Shelake

Abstract: Quality assurance plays a crucial role in pharmaceutical manufacturing to ensure the safety, efficacy, and compliance of medicinal products. Regulatory bodies worldwide impose stringent requirements on pharmaceutical manufacturers to adhere to good manufacturing practices (GMP) and other quality standards. This paper examines current trends and future directions in quality assurance strategies for ensuring compliance in pharmaceutical manufacturing. It explores key elements of an effective quality assurance program, such as risk management, process validation, supplier qualification, and data integrity. Additionally, it highlights emerging technologies, such as advanced analytics, artificial intelligence, and blockchain, and their potential to revolutionize quality assurance in the pharmaceutical industry. By understanding the current landscape and anticipating future developments, pharmaceutical manufacturers can proactively implement strategies to enhance compliance and deliver high-quality products to patients.

Keywords: Quality assurance, Compliance, Quality by Design Pharmaceutical manufacturing GMP (Good Manufacturing Practices), Process validation, (QbD, Supplier qualification, Data integrity, Risk management, Regulatory requirements

Authors:  Prashant kumar, Anupam Rawat, A K Sachan

Abstract: Pharmacovigilance is an essential component of ensuring drug safety and minimizing adverse drug reactions. Traditionally, pharmacovigilance has been a healthcare professional-driven process, relying on healthcare providers and regulatory authorities to report adverse events. However, there is growing recognition of the crucial role that patients can play in enhancing drug safety. Patient engagement in pharmacovigilance involves actively involving patients in the monitoring, reporting, and management of adverse drug reactions. This paper explores the importance of patient engagement in pharmacovigilance, its benefits, challenges, and strategies to empower patients for effective drug safety.

Keywords: Patient engagement, pharmacovigilance, adverse drug reactions, drug safety, patient empowerment, adverse event reporting, safety signals, drug safety communication, patient awareness, patient education, reporting systems, healthcare provider training, data quality, ethical considerations.

Authrs: Vishawas Sinha, Kamlesh Pratap

Abstract: Quality by design (QbD) is the modern method to ensuring pharmaceutical safety and efficacy. This review describes quality by design and identifies some of its features to assure pharmaceutical quality. Each unit operation's process parameters and quality characteristics are identified. This article discusses the advantages, opportunities, and procedures involved in pharmaceutical product quality through design. The ICH quality recommendations Q8, Q9, and Q10 for pharmaceutical development, quality risk management, and pharmaceutical quality systems, respectively, provide examples of how to use quality by design in pharmaceutical development and manufacture.The goal of pharmaceutical development is to create a high-quality product and manufacturing method that consistently delivers the product's expected performance. Throughout the product's development, steps should be done to add to or improve its quality. It contains the Quality goal product profile, vital quality attributes, and other important Quality by Design features. QbD also compares the quality of a product based on end-product testing to the quality of a product based on quality by design. Quality by Design is a concept that was described and presented in an international conference for harmonisation.

Keywords: Critical quality attributes, critical material attributes, critical process parameters, international conference for harmonization, quality by design, quality target product profile

Authors: Barsha Dewan, Mashrar Faujdar

Abstract: A country's national pharmacovigilance centre manages total pharmacovigilance work in coordination with international regulatory agencies such as WHO-UMC, etc. The introduction of a pharmacovigilance system in public health has had a positive influence on the improvement of the health-care system. DGDA is leading from the front to safeguard the safety of Bangladesh's medicine system. The DGDA was designated as the National Pharmacovigilance Centre for Bangladesh by the Ministry of Health and Family Welfare in 2013, with the ADRM cell monitoring the center's work. The MOHFW has established an independent ADR Advisory Committee to collaborate with the ADRM cell in providing technical assistance for PV operations, analysing ADE reports, and suggesting regulatory choices and steps to safeguard medication safety. In collaboration with all stakeholders, the DGDA has produced guidelines and plans for implementing PV initiatives across the country. The following are the key aspects of current PV legislation in Bangladesh: A suitable PV system is installed within the firm to undertake post-marketing monitoring operations; Suspected adverse drug reactions must be reported using the electronic version of the reporting form, which is accessible in fillable pdf format on the DGDA website, and sent to the ADRM cell. Quarterly submit PSURs and company-sponsored post-registration study reports to the ADRM cell; Respond to ADRM cell requests for risk/benefit information immediately and completely.

Keywords: Pharmacovigilance; WHO-UMC; DGDA; ADR; ADE; ADRM Cell; MOHFW; ADRAC; PSUR; RMP; Serious Adverse Event

Authors: Puneet Pandey, Pankaj Singh, Mehul Saktawat

Abstract: The significance of internal audits for the pharmaceutical industry, as stated in the recommendations for excellent pharmacy practises (in particular, GMP, GDP).The topic of auditor selection, training, grading, certification, and continual development in pharmaceutical firms is relevant and vital for both local and international enterprises. The study's goal was to identify the competency of pharmacy quality system internal auditors and opportunities for growth.Materials and methods. The study's focus was on the competency of pharmaceutical quality system internal auditors. Empirical and theoretical research methodologies were employed, most notably the method of comparative analysis of scientific literature in the subject of study, as well as the method of structural and logical modelling. The terms of rules and materials available in open professional scientific literature served as the information foundation.Results The capability of the quality management system Personal attributes, professional knowledge, and abilities are required of auditors in general, and pharmaceutical quality systems in particular. The ISO 19011 standard emphasises the significance of evaluating and continuously developing auditor competence. Such an evaluation should take into consideration the audit program's requirements and objectives. The details of industrial activities should decide the areas of growth of auditors' competence. This standard requirement should be deemed significant for pharmaceutical businesses.Conclusions. We investigated the requirements for the competency of QMS internal auditors in accordance with international and industry standards. A assessment of the regulatory framework revealed a dearth of information on the research topic of choice. Defined standards for the competency of PQM audits personnel aid in the selection of specialists for the audit team so that the audit team's total competence is sufficient to meet the audit's objectives.

Keywords: internal audit, auditor, quality management system, pharmaceutical quality system, ISO 9001, ISO 19011, phar- maceutical company, auditor competence.

Authors: Meenakshi Tyagi, Sandeep Soni

Abstract: Despite its wealth, India has inadequate health care due to a dearth of skilled pharmacists and the necessity of pharmacists. Due to unclean conditions and a lack of awareness, rural populations suffer from a variety of communicable and infectious diseases, whereas urban inhabitants suffer from lifestyle diseases while maintaining hygienic conditions due to variables such as pollution, lifestyle, and stress. Because the pharmacist is an immediately available health practitioner, he should be involved in sickness prevention and treatment. We will look at generic drugs, lifestyle modifications, establishing drug information centres, avoiding antibiotic resistance, implementing smoking cessation and awareness programmes, raising immunisation rates, and focusing on clinical research and pharmacovigilance in this review. As a result, pharmacists may play a variety of roles, from dispensing to providing whole patient care, hence enhancing patients' treatment outcomes. The primary qualification for these occupations is interaction between the pharmacist and the patient, which necessitates a consulting room in each drugstore. The nation's health improves when the government recognises the significance of pharmacists and gives opportunities for them to contribute to society. Aspects in which the pharmacist should be involved to maximise his efforts to enhance health in society. A healthy Pharma nation may be achieved by including pharmacists into many areas such as good patient consultation, educating people on the importance of pharmacists, and giving opportunities for pharmacists to contribute to society.

Keyword: Pharmacist Role, Patient Health Promotion, Lifestyle, Smoking Cessation.